Call us directly: +44 (0)7905 201857

Email us

Members log in

SEHTA Advisers

SEHTA has expert associates in Telecare, Telehealth and Telemedicine, ICT, diagnostics, medical devices, pharmaceuticals, regulations, standards, ICT funding, event management, IP protection, government policy, social policy and services, marketing, the NHS.

Assisted Living Adviser

Dr Richard Curry , e-health Development Director

Richard is the e-health Development Director for SEHTA and is the Founder of the SEHTA initiative in Telecare (ICE-T). He is also an independent consultant specialising in telemedicine and telecare and has authored several reports on aspects of telemedicine and telecare for Government. He has worked with a number of NHS Trusts, District Councils and Charities helping them to implement telemedicine and telecare programmes. He is also a Senior Research Fellow at University of Portsmouth where he is actively engaged in research into assisted living.

Until recently he was Senior Scientific Adviser to the Department of Health’s research initiative on the role of technology in supporting chronic disease management, self care and healthy living and an adviser to the Technology Strategy Board (TSB) on their Assisted Living Innovation platform.

He holds a PhD in physics from the University of Durham and is a Fellow of the Royal Society of Medicine.


Biopharmaceutical Adviser

Dr Mark Edwards

Mark is a medically-qualified (specialist training in anaesthesia and critical care) and GMC- registered drug Mark Edwards 2017developer with 25 years’ pharmaceutical R&D experience. Formerly, he was a Global Clinical R&D Director and then Director of Science and Medical Public Affairs at Pfizer in Sandwich, Kent. He has worked at all phases of clinical development across a wide variety of therapeutic areas. This includes regulatory product approval experience, having successfully led Pfizer’s global clinical development team to achieve the US/EU registration of sildenafil as a first-in-class treatment for pulmonary arterial hypertension.

His experience has also included the establishment of major R&D projects at the interfaces between academia, the NHS and the biopharmaceutical industry e.g. having helped lead the establishment of 1) MRC/industry pre-competitive consortia in COPD and RA and 2) the UK Government’s Translational Research Partnership Programme.

Now he provides strategic and applied clinical, scientific and policy advice to life sciences organisations throughout the public, private and charitable sectors. He was R&D Director of The Ethical Medicines Industry Group (EMIG) for which he established de novo a strong scientific & medical arm to complement the commercial interests of the association. This was pivotal to grow and diversify EMIG’s membership to include a broad range of charitable organisations in addition to biopharma.

Mark is a Non-Executive Director of the SW Academic Health Science Network (SWAHSN).

For more information about Mark, please click on his full bio Dr Mark Edwards Full Bio or email or Follow Mark on LinkedIn

Medical Technology Adviser

Neil Roberts

Neil has spent more than 25 years in the medical technology market, with a track record of success in driving business development and growth, via sales and marketing, domestic and Neil Roberts SEHTA photointernational distributor management, market access, major accounts, new business integration, and change management. Gained in the UK and in export within an SME and leading Med Tech company environment.

His areas of expertise cover a large range of medical applications and technologies including; Ophthalmic imaging, diagnosis and consumables, Cardiology, Oncology treatment, Care of the Elderly, Surgical visualisation and lasers, Wound care, Anaesthesia delivery and theatre monitoring, Dermatology, Colposcopy, ENT, and EEG/EMG/EP in neurology.

His approach is based on pragmatism, enabled by detailed market understanding, with the highest importance placed on the execution of consequent action plans as the key to success.

He has managed product though NICE Technology Appraisal (TA), and other market access processes.

Served as Industry Representative on the RCOphth Working Party into the safety of laser eye surgery in the UK, and as Chair of the Ophthalmic Special Interest Group at the ABHI.

A degree in Medical Biochemistry from London University has been enhanced by business management education at Ashridge and the completion of leadership courses from Harvard.

Public Health Adviser

Professor William Maton-Howarth

Bill was, until 2012 Chief Research Officer for Public Health at the Department of Health, where he was responsible for overseeing policy research in areas including antimicrobial resistance, eHealth, risk, vCJD, health protection, health care associated infection, new and emerging infections, hepatitis, and Less Invasive Autopsy. In this role Bill lead the Invention for Innovation (i4i) Programme and worked closely in collaboration with the Technology Strategy Board in establishing the Assisted Living Innovation Platform (ALIP), the Detection and Identification of Infectious agents (DIIA) Innovation Platform, and took a lead role in piloting and developing the renewed cross Government Small Business Research Initiative (SBRI) Programme.

Medical Devices Adviser

Les Plant

Les has 30 years proven experience in all the major healthcare markets of the world. In his most recent role as a Biotech & Healthcare InternationalLes Plant Trade Adviser, Les has made regular visits to Saudi Arabia and the surrounding Gulf States.

His knowledge encompasses Capital Equipment, Disposables, Medical Devices, Rehabilitation, Assistive Technology, Care of the Elderly & Special Needs, Turnkey and Package Deal operations.

Business management skills include; forecasting, budget preparation and control, strategic projections and     new product policies. The selection, motivation and management of distributors and agents are keys element in his skill base.

Clinical Adviser – Health and Wellbeing

Dr Tim Anstiss, MB, MEd, D.Occ.Med, MFSEM

As a medical doctor with a master’s degree in sports medicine and a diploma in occuTim Anstisspational medicine, Tim has worked in variety of medical settings including cardiology, orthopaedics, psychiatry, research, rehabilitation, community, drug and alcohol and public health. Tim’s main interest is in and around health behaviour change, motivational interviewing, health coaching, cognitive-behavioural approaches and health and wellbeing improvement – including mindfulness and compassion focussed approaches. A member of the British Psychological Society, Tim has recently been running training programmes for clinical directors and healthcare managers, helping them cultivate more positive and productive workplaces using coaching, solution focussed and strengths-based ways of working. He is currently running a 7 Trust collaborative for the London NHS Partnership, helping bring about healthcare improvement using Appreciative Inquiry.

Tim has recently turned his attention to developing e-health and m-health solutions, creating an interactive online wellbeing and resilience portal in partnership with the University of London Computer Centre and a telehealth / telemental health coaching solution in partnership with a US software company.

Clinical Adviser – Geriatrics

Dr Beverly Castleton, MA MB BCHIR FRCP
Beverly Castleton

Beverly trained at Cambridge University and UCH. She is a Consultant Physician in the Care of the Elderly and specialises in treating people with Parkinson’s Disease and Related Disorders. She has lectured extensively on the management of these Movement Disorders. Beverly was a Clinical Advisor to S.E. Coast Strategic Health Authority and Surrey Primary Care Trust, and is a member of the Southern Combined Clinical Advisory Group for IT. Beverly’s research interests lie in the management of Parkinson’s Disease and how the utilisation of Telehealth and Telecare systems can help patients and carers cope with Long Term Conditions.

Beverly is past President of the Royal Society of Medicine’s Telemedicine and eHealth Section.

Diagnostics Adviser

David Wilson

David has over 20 years progressive international experience in business development, marketing, strategy development, licensing, sales channel management,  and product/technology david wilsonassessments, with a focus on the in vitro diagnostics (IVD) industry. He is currently Vice President, Commercial Operations Europe for Molecular Detection Inc., a VC-funded, early commercial stage molecular diagnostics company with focus on rapid detection of infectious diseases. David also serves as Managing Director of Bioscience Business Resources Ltd, a specialist consultancy which he established in 2007 to meet a growing demand from companies based outside the EU for help establishing routes to European markets for health technologies, particularly markets for in vitro diagnostic products. Additionally as Diagnostics Business Adviser for South East Health Technologies Alliance (SEHTA) he supports the commercial development of IVD businesses based mainly in the vibrant health technologies cluster in the south east of England.

Previously, David has held senior commercial roles at Genzyme Corporation, in both Genzyme Diagnostics and Genzyme Molecular Oncology business units, and most recently was Business Development Director for Genzyme Diagnostics (now Sekisui Diagnostics). In this role he was responsible for the identification, screening and commercial evaluation of new products, platform technologies and businesses for acquisition. He has been an Innovation Advisor with the publically funded Innovation Advisory Service, managed by Oxford Innovation Ltd, and a non-executive director and founding member of the South East Health Technologies Alliance (SEHTA).

David has an MBA from the Open University Business School and a BSc (Hons) in Biochemistry with Microbiology from the University of St Andrews. He has studied at the University of California at Santa Barbara and has published research in molecular oncology carried out at the Imperial Cancer Research Fund (now Cancer Research UK).

Policy & Health Economics Adviser

Prof James Barlow

James has held a Chair in Technology and Innovation Management at Imperial College James BarlowBusiness School since 2003. James has been Principal Investigator of HaCIRIC, the world’s largest research centre focusing on healthcare infrastructure research, since its inception in 2006.

He is also a member of the executive for the UK Department of Health’s Policy Innovation Research Unit (PIRU) and the European Centre for Health Assets and Architecture (ECHAA). He holds a PhD from the London School of Economics and Political Science. Previous appointments include the University of Sussex and Policy Studies Institute.James’ research focuses on the adoption, implementation and sustainability of innovation in healthcare systems. This has included extensive work on the development and introduction of ‘remote care’ and research on the use of public-private partnerships in healthcare infrastructure. He works closely with UK and international companies, the UK’s National Health Services and with government at a strategic policy level.  He has been a member of many expert panels on healthcare innovation and currently sits on the healthcare advisory board for MITIE Group plc. James is also an advisory board member of the Guy’s and St Thomas’ Hospital Charity Strategy Committee, supporting investment in local innovation projects.He has published widely, including numerous journal articles and four books.

Health & Social Care Adviser (Service Development/Large Corporates)

Dr Mike Sadler
Mike Sadler 1

Mike is Clinical Non-Executive Director at Southern Health NHS Foundation Trust, and is adding a portfolio of advisory roles to that appointment. His last full time role, up until July 2013 when he commenced the above appointment, was as Director of Health and Social Care Commissioning at West Sussex County Council.

Mike qualified in Medicine in Nottingham, and was a GP principal in Hampshire before moving into Public Health Medicine. Having achieved MSc with Distinction at the London School of Hygiene and Tropical Medicine, he joined Portsmouth and South East Hampshire Health Authority, holding the joint posts of Deputy Director of Public Health, and Medical Adviser. He has since held a series of senior clinical leadership roles in national organisations in both the public and private sector, including as Chief Operating Officer at NHS Direct, and then as Chief Operating Officer for Serco’s Health Division.

Mike thus has an enormous breadth of experience, having been a leader, manager, clinician, provider, commissioner, operational lead, policy maker, and quality assessor, working within both the public and private sectors, and within both the health service and local government.

Commercialization Adviser (Technology Enabled Care)

Joanne Jenkins

Joanne uses her research skills and passion for innovation and technology to help organizations specializing in technology-enabled care and wellbeing to create Joanne Jenkinsmarket-led solutions and exploit market opportunities.

Joanne draws on her background in the commercialization of innovation and new product development to support high-growth innovating technology businesses; her research work ensures up-to-the-minute sector knowledge; and her extensive network of sector contacts facilitates collaboration opportunities for research, industry, and care professionals.

Joanne joined SEHTA in 2010 to provide project management and grant management expertise to the ICE-T (International Centre of Excellence in Telecare) project. Since then she has focused on assisted living technology and healthy ageing, expanding her role to include sector-specific research and market analysis, as well as ensuring the delivery of assisted living projects funded by the Technology Strategy Board and EU.

Prior to joining SEHTA, Joanne provided support to technology and high-growth businesses as a Portfolio Director with the Surrey Enterprise Hub and as Community of Innovation Manager for the W Surrey & NE Hants Innovation & Growth team. These roles involved providing intensive commercialization support and investment readiness preparation to businesses as well as providing access to funding and grants to facilitate bringing new products to market. Other key initiatives focused on building innovation networks and providing businesses with R&D, supply-chain and open innovation opportunities.

Contact Joanne via LinkedIn